Vertical integration continues to reshape U.S. healthcare, as detailed in Drug Channel Institute’s new 2025-26 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. In recent years, these companies have spent more than $16 billion to acquire management service organizations (MSOs) that oversee physician practices in such specialties as gastroenterology, oncology, ophthalmology, and urology. Below, DCI highlights the largest MSO transactions and explore five ways wholesalers benefit from ownership in their downstream physician customers. Ultimately, these strategies may allow wholesalers to exert unprecedented control over market access for provider-administered drugs—if they can figure out how to realize this power.
Read the full article: The Future of Buy-and-Bill Market Access: Five Drivers of Wholesalers’ Vertical Integration with Physician Practices //
Source: https://www.drugchannels.net/2025/10/the-future-of-buy-and-bill-market.html